We are live on ! Find out more
AKCA

Akcea Therapeutics Inc
AKCA

Delisted

AKCA was delisted on the 9th of October, 2020.

Back to rankings

Fund managers haven’t disclosed any holdings of AKCA yet.

AKCA Hedge Fund Activity: Q4 2020 in Review

0 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Akcea Therapeutics Inc (AKCA) for Q4 2020, worth a combined $0 — down 100% from $287M a quarter earlier.

Sellers outnumbered buyers: 98 funds closed out of AKCA and 0 opened new positions — a net loss of 98 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $104M sold.

  • 0 institutional investors held Akcea Therapeutics Inc (AKCA) as of Q4 2020, down from 98 in Q3 2020.
  • Funds reported $0 of Akcea Therapeutics Inc stock for Q4 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Akcea Therapeutics Inc positions in Q4 2020 and 98 closed out, a net change of -98 holders.
  • The largest Akcea Therapeutics Inc seller in Q4 2020 was Fidelity Investments, an estimated $104M sold.

Based on aggregated 13F filings for Q4 2020.